|
|
| Line 1: |
Line 1: |
| The overall poor prognosis of stent thrombosis makes this rare complication, a devastating and hence extremely inportant one. A sub-analysis of TRITON-TIMI 38 study showed that stent thrombosis was associated with death or myocardial infarction in 89% (186/210) of patients<ref name="pmid18377975">{{cite journal |author=Wiviott SD, Braunwald E, McCabe CH, ''et al.'' |title=Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial |journal=Lancet |volume=371 |issue=9621 |pages=1353–63 |year=2008 |month=April |pmid=18377975 |doi=10.1016/S0140-6736(08)60422-5 |url=}}</ref>. In follow up studies after stent thrombosis, recurrent stent thrombosis has also been noticed, especially during the following six months<ref name="pmid19232197">{{cite journal |author=Gallego L, Martínez-Sellés M, García E, ''et al.'' |title=Characteristics and outcome of angiographically confirmed stent thrombosis |journal=Rev Esp Cardiol |volume=62 |issue=2 |pages=220–3 |year=2009 |month=February |pmid=19232197 |doi= |url=}}</ref>.
| |
|
| |
|
| Van Werkum et al<ref name="pmid19188507">{{cite journal |author=van Werkum JW, Heestermans AA, de Korte FI, ''et al.'' |title=Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases |journal=Circulation |volume=119 |issue=6 |pages=828–34 |year=2009 |month=February |pmid=19188507 |doi=10.1161/CIRCULATIONAHA.108.799403 |url=}}</ref> studied the long term outcome after definite stent thrombosis. 431 patients with definite stent thrombosis were enrolled in this multicenter registry. The primary end point was the composite of cardiac death and definite recurrent ST. The primary end point occurred in 111 patients after a median follow-up of 27.1 months. Clinical outcome was not affected by the type of previously implanted stent (drug-eluting or bare-metal stent) or the category of ST (early versus late). Authors concluded that the long-term clinical outcome after a first definite ST is unfavorable, with a high mortality and recurrence rate. Diabetes mellitus, left ventricular ejection fraction <45%, long total stent length, complex coronary lesions, TIMI flow grade <3 after percutaneous coronary intervention, and implantation of an additional coronary stent during the emergent percutaneous coronary intervention for the ST were associated with this unfavorable outcome.
| |
|
| |
|
| |
| ==References==
| |
| {{reflist|2}}
| |